The Global Tretinoin Market is anticipated to gain popularity over the coming years as tretinoin products are used to treat acute promyelocytic leukemia and acne. This information was announced by Fortune Business Insights in a report, titled “Tretinoin Market Size, Share and Global Trend By Application (Acne, Acute Promyelocytic Leukemia (APL)), By Strength (0.025%, 0.01%, 0.05%, 0.1%), By Distribution Channel (Hospitals and Clinics Pharmacies, Retail Pharmacies, Online Pharmacies), By Route of administration (Topical Applications, Oral), Geography Forecast till 2026.” Tretinoin also referred to as Retin-A helps to treat skin discoloration and aging.
Browse Complete Report Details @https://www.fortunebusinessinsights.com/industry-reports/tretinoin-market-100194
The report mentions that the demand for tretinoin products in hospitals, retail, and online pharmacies is likely to increase in the coming years. Furthermore, as per the report, acne treatment accounts for a major share in the global market at present and continues to remain strong in the forecast years. This is ascribable to the rising use of tretinoin for acne vulgaris as compared to acute promyelocytic leukemia.
Some of the Main Key Players Covered in the Report
- Sun Pharma Advanced Research Company Ltd.
- Glaxosmithkline Inc.
- Janssen Inc.
- Bausch Health Companies Inc.
- Ortho Dermatologics
Adverse Effects of Tretinoin Products May Hamper Growth
Certain factors that may inhibit the growth of the market include side effects of tretinoin products. These side effects such as itching, excessive dryness, redness, and scaling may restrict the market’s growth. Also, administration of tretinoin for the treatment of leukaemia can have some side effects such as retinoic acid syndrome, liver damage, hypertension and others. These side-effects may pose a serious threat to the market during the forecast duration.
Demand for Tretinoin Products is the Highest in North America and Europe
Among regions, North America and Europe are anticipated to hold a major share in the global tretinoin market throughout the forecast years. The rising prevalence of acne vulgaris in the U.S. is the main factor likely to drive the market in this region. Also, rising FDA approvals for the treatment of acne is expected to create growth opportunities for the market by 2026.
Well-established healthcare infrastructure is expected to encourage growth in the market in Europe by 2026. The market in the Asia Pacific is likely to register considerable growth during the forecast period. Japan is projected to offer the largest market opportunity owing to the presence of a drug manufacturer called Chugai. The manufacturing unit is controlled by F. Hoffmann-La Roche AG in Japan.
Extensive Use of Tretinoin Products Stimulates Growth in the Market
Tretinoin, a derivative of vitamin A helps to treat mild to moderate acne on the skin, which is damaged by excessive sun exposure. Other benefits offered by tretinoin include treatment for hyperpigmentation and wrinkles. As per research studies, use of tretinoin cream over a long term helps to reduce the visibility of skin aging symptoms. The report predicts such benefits to augment demand for tretinoin cream and tretinoin microsphere gel in the coming years.
“Launch of new products and existing number of products for all-trans retinoic acid leukemia are likely to drive the market,” stated a lead analyst at Fortune Business Insights. “The demand for such products in different strengths and forms is expected to increase, which is indicative of boosting the tretinoin market,” he added.
More Trending Topics from Future Business Insights: